Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Oster

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
Cancer|May 15, 1982
Ocular side effects of cancer chemotherapyM Vizel, M W Oster
International Journal of Cell Cloning|January 1, 1989
Role of colony-stimulating factors in the biology of acute myelogenous leukemiaW Oster, R Mertelsmann, F Herrmann
Medical and Pediatric Oncology|January 1, 1981
Myocardial injury immediately following adriamycin administrationM W Oster, T J Rakowski
Biotechnology Therapeutics|January 1, 1991
Interleukin-1, characterization of the molecule, functional activity, and clinical implicationsD Brazel, S Nakanishi, W Oster
Haematology and Blood Transfusion|January 1, 1990
Mechanisms of autocrine and paracrine growth control in acute myelogenous leukemiaW Oster, R Mertelsmann, F Hermann
Anti-Cancer Drugs|January 1, 1997
Effects of WR-2721 (amifostine) and its metabolite WR-1065 on the antiproliferative activity of chemotherapeutic agents on neuroblastoma cells in vitroS Fulda, W Oster, F Berthold
Pharmacology & Therapeutics|October 1, 1991
Adjuvant therapy with recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factorG Schulz, D Krumwieh, W Oster
Behring Institute Mitteilungen|December 1, 1991
Clinical evaluation of erythropoietin (EPO) in oncologyW Oster, F Schindel, H Heinrichs
Contributions to Nephrology|January 1, 1991
Treatment of patients with anemia of malignancy with recombinant human erythropoietinF Herrmann, W Oster, R Mertelsmann
Klinische Padiatrie|July 1, 1990
Control of blast cell proliferation and differentiation in acute myelogenous leukemia by soluble polypeptide growth factorsF Herrmann, W Oster, R Mertelsmann
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Cancer|May 15, 1982
Ocular side effects of cancer chemotherapyM Vizel, M W Oster
International Journal of Cell Cloning|January 1, 1989
Role of colony-stimulating factors in the biology of acute myelogenous leukemiaW Oster, R Mertelsmann, F Herrmann
Medical and Pediatric Oncology|January 1, 1981
Myocardial injury immediately following adriamycin administrationM W Oster, T J Rakowski
Biotechnology Therapeutics|January 1, 1991
Interleukin-1, characterization of the molecule, functional activity, and clinical implicationsD Brazel, S Nakanishi, W Oster
Haematology and Blood Transfusion|January 1, 1990
Mechanisms of autocrine and paracrine growth control in acute myelogenous leukemiaW Oster, R Mertelsmann, F Hermann
Anti-Cancer Drugs|January 1, 1997
Effects of WR-2721 (amifostine) and its metabolite WR-1065 on the antiproliferative activity of chemotherapeutic agents on neuroblastoma cells in vitroS Fulda, W Oster, F Berthold
Pharmacology & Therapeutics|October 1, 1991
Adjuvant therapy with recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factorG Schulz, D Krumwieh, W Oster
Behring Institute Mitteilungen|December 1, 1991
Clinical evaluation of erythropoietin (EPO) in oncologyW Oster, F Schindel, H Heinrichs
Contributions to Nephrology|January 1, 1991
Treatment of patients with anemia of malignancy with recombinant human erythropoietinF Herrmann, W Oster, R Mertelsmann
Klinische Padiatrie|July 1, 1990
Control of blast cell proliferation and differentiation in acute myelogenous leukemia by soluble polypeptide growth factorsF Herrmann, W Oster, R Mertelsmann
Pageof 12